Sign in
Home
News
About Us
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Knox Daily
Opinion Matters
Home
News
About Us
Contact Us
Home
Tags
Fate Therapeutics Inc.
Tag: Fate Therapeutics Inc.
Analysts Viewpoint
FATE (Fate Therapeutics Inc.) may reap gains as insiders became active recently
Anna Perez
-
March 20, 2023
0
Insiders Updates
Insider Buying: MENDLEIN JOHN, Fate Therapeutics Inc. [FATE] Director invested 36,631 shares
Jaxson Clark
-
March 16, 2023
0
Insiders Updates
Investing in Fate Therapeutics Inc. (FATE): What You Must Know
Samantha Gray
-
March 13, 2023
0
Analysts Viewpoint
Director MENDLEIN JOHN acquire 36,631 shares of Fate Therapeutics Inc. [FATE]
Anna Perez
-
March 9, 2023
0
Stock Earnings
FATE (Fate Therapeutics Inc.) may reap gains as insiders became active recently
Samantha Gray
-
March 6, 2023
0
Insiders Updates
A company insider recently bought 36,631 shares of Fate Therapeutics Inc. [FATE]. Should You Buy?
Roman Campbell
-
March 2, 2023
0
Analysts Viewpoint
Investing in Fate Therapeutics Inc. (FATE) Is Getting More Attractive
Jaxson Clark
-
February 27, 2023
0
![Insider Buying: MENDLEIN JOHN, Fate Therapeutics Inc. [FATE] Director invested 36,631 shares](https://knoxdaily.com/wp-content/uploads/2020/09/pexels-andrea-piacquadio-3823493.jpg "Insider Buying: MENDLEIN JOHN, Fate Therapeutics Inc. [FATE] Director invested 36,631 shares")
![Director MENDLEIN JOHN acquire 36,631 shares of Fate Therapeutics Inc. [FATE]](https://knoxdaily.com/wp-content/uploads/2020/10/Image-84.png "Director MENDLEIN JOHN acquire 36,631 shares of Fate Therapeutics Inc. [FATE]")
![A company insider recently bought 36,631 shares of Fate Therapeutics Inc. [FATE]. Should You Buy?](https://knoxdaily.com/wp-content/uploads/2020/09/skyscrapers-5516866_640.jpg "A company insider recently bought 36,631 shares of Fate Therapeutics Inc. [FATE]. Should You Buy?")
